Company attributes
Industry
B2X
0
CEO
AngelList URL
Pitchbook URL
Legal Name
Cellectar Biosciences, Inc.
Number of Employees (Ranges)
11 – 50
Email Address
investors@cellectar.com0
Phone Number
+160844181200
Full Address
100 Campus Drive, Suite 207 Florham Park, NJ 079320
CIK Number
Place of Incorporation
Investors
DUNS Number
1726264130
IRS Number
43,321,8040
Total Funding Amount (USD)
5,100,000
Latest Funding Round Date
April 11, 2011
Stock Symbol
CLRB0
Exchange
Board of Directors
Acquisition Transaction
NAICS Code
325,4120
CAGE Code
4BFM00
Patents Assigned (Count)
18
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Previous Name
NOVELOS THERAPEUTICS, INC.0
COMMON HORIZONS INC0
SIC Code
2,8340
Ticker Symbol
CLRB
Cellectar Biosciences Inc. is a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. It is developing proprietary drugs independently and through research and development collaborations with a core objective to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
